European Urology

Viewing slides 1-6 of 8

• S0302-2838(10)00788-8.title drag remove slide sort drag into slide Title Retroperitoneal Lymph Node Dissection with No Adjuvant Chemotherapy in Clinical Stage I Nonseminomatous Germ Cell Tumours: Long-Term Outcome and Analysis of Risk Factors of Recurrence Retroperitoneal Lymph Node Dissection with No Adjuvant Chemotherapy in Clinical Stage I ... Zoom
• S0302-2838(10)00788-8.introduction drag remove slide sort drag into slide Introduction Management of patients with clinical stage I (CS1) nons-eminomatous germ-cell tumours(NSGCT) is still under debate.
  
  Retroperitoneal lymph node dissection (RPLND) is gradually being replaced by ... Management of patients with clinical stage I (CS1) nons-eminomatous germ-cell tumours(NSGCT) is ... Zoom
• 17809 drag remove slide sort drag into slide Crude cumulative incidence curves of tumour recurrence and contralateral germ ... Zoom read this article »
• 17811 drag remove slide sort drag into slide Relationship between the recurrence risk, expressed as log odds from the Table ... Zoom read this article »
• 17813 drag remove slide sort drag into slide (A) Box plots of recurrence probability predicted from the Table 3 logistic ... Zoom read this article »
• S0302-2838(10)00788-8.materials_and_methods drag remove slide sort drag into slide Materials and methods We evaluated the long-term oncologic outcome of 322 consecutive CS1 NSGCT patients underoing RPLND between 1985 and1995 not followed by adjuvant chemotherapy.
  
  Table 1 shows Patients were followed ... We evaluated the long-term oncologic outcome of 322 consecutive CS1 NSGCT patients underoing RPLND ... Zoom

Viewing slides 1-6 of 8